Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity. (2017)
Attributed to:
Definition and induction of broadly protective responses against HIV-1
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/21645515.2017.1316911
PubMed Identifier: 28426273
Publication URI: http://europepmc.org/abstract/MED/28426273
Type: Journal Article/Review
Volume: 13
Parent Publication: Human vaccines & immunotherapeutics
Issue: 8
ISSN: 2164-5515